| Temsirolimus |
ENSG00000100181.17 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000125804.9 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000136315.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000146666.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000146666.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000153363.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000163597.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000164621.5 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000167117.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000167912.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000170919.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000175147.7 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000175772.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000175773.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000176728.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000177757.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000179406.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000179523.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000182057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000182109.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000182648.7 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000183674.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000185203.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000185203.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000189229.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000196668.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000197210.7 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000197813.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000197813.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000203288.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000203321.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000203650.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000203721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000203808.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000203875.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000204588.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000204625.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000204625.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000204666.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000204758.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000205041.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000205181.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000205266.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000205890.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000206140.5 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000212163.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000212163.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000213468.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000213793.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000213994.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000214401.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000214407.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000214650.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000214650.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000214650.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000214772.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000214894.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000214955.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000215068.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000215241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000215394.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000215447.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000215483.4 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000215498.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000215692.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000215866.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000222041.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000223374.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000223382.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000223396.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000223396.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000223414.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000223473.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000223477.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000223477.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000223478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000223478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000223478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000223635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000223660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000223685.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000223714.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000223714.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000223714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000223715.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000223749.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000223784.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000223784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000223791.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000223975.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000224023.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000224057.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000224138.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000224138.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000224142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000224157.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000224165.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000224271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000224294.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000224363.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000224409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000224441.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000224441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000224460.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000224481.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000224533.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000224533.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000224536.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000224536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000224536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000224549.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000224635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000224644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000224655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000224729.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000224761.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000224764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000224794.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000224794.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000224804.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000224804.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000224804.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000224846.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000224884.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000224888.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000224905.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000224930.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000224959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000224961.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000224969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000225037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000225037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000225039.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000225077.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000225077.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000225092.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000225111.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000225138.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000225163.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000225187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000225218.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000225235.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000225278.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000225331.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000225489.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000225489.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000225493.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000225506.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000225518.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000225532.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000225555.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000225578.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000225611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000225649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000225675.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000225675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000225676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000225744.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000225761.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000225764.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000225793.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000225836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000225857.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000225886.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000225891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000225945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000225956.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000225963.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000225969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000225981.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000226026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000226026.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000226125.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000226386.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000226440.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000226453.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000226465.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000226548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000226574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000226609.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000226645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000226645.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000226696.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000226747.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000226833.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000226835.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000226856.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000226877.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000226957.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000227028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000227036.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000227071.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000227071.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000227094.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000227172.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000227252.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000227258.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000227290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000227301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000227308.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000227359.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000227400.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000227400.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000227403.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000227455.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000227496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000227543.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000227637.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000227640.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000227698.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000227773.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000227811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000227914.3 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000227959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000228021.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000228108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000228109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000228115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000228141.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000228172.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000228172.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000228222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000228288.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000228288.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000228313.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000228369.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000228386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000228412.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000228420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000228422.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000228452.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000228478.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000228485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000228509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000228544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000228643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000228697.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000228701.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000228737.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000228737.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000228775.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000228779.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000228801.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000228802.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000228809.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000228817.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000228852.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000228857.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000228886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000228906.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000228962.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000228972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000228973.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000228988.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000228989.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000229021.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000229081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000229081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000229152.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000229162.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000229190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000229278.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000229278.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000229278.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000229388.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000229395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000229484.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000229512.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000229512.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000229521.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000229521.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000229589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000229694.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000229739.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000229780.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000229841.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000229862.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000229869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000229869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000229869.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000229891.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000229891.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000229952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000229953.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000230002.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000230010.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000230013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000230020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000230074.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000230082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000230107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000230113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000230148.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000230148.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000230176.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000230289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000230310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000230316.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000230333.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000230415.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000230454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000230487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000230499.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000230499.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000230523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000230530.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000230552.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000230561.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000230658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000230679.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000230747.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000230836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000230836.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000230839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000230881.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000230914.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000230937.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000230939.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000231064.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000231083.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000231113.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000231121.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000231172.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000231187.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231187.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000231208.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000231212.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000231242.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000231242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231249.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000231298.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000231327.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000231327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231441.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000231507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231521.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000231563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000231575.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000231607.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231616.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000231638.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000231663.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000231704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000231721.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000231728.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000231742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000231756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000231770.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000231811.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231817.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000231908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000231943.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000231948.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000231999.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000232082.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000232098.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000232116.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000232117.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000232224.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000232229.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000232310.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000232311.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000232311.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000232316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000232324.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000232352.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000232401.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000232411.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000232455.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000232485.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000232533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000232542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000232555.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000232586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000232586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000232611.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000232613.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000232648.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000232692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000232694.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000232725.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000232739.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000232754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000232762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000232814.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000232874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000232874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000232900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000232931.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000232934.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000232956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000233006.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000233008.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000233033.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000233038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233061.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000233067.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000233081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000233110.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233143.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000233143.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000233203.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000233223.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000233237.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000233237.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233246.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000233246.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000233332.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000233396.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000233411.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000233411.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000233429.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000233483.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000233501.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000233554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000233611.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000233611.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000233613.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000233613.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000233791.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000233799.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000233799.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233825.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000233825.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000233845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000233847.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233854.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000233864.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000233871.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000233901.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000233912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000233930.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000233967.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000234019.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000234062.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000234072.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000234134.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000234155.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000234160.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000234185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000234185.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000234222.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000234225.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000234230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000234233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000234290.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000234323.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000234336.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000234352.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000234362.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000234478.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000234567.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000234584.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000234601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000234616.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000234626.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000234678.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000234694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000234722.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000234741.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000234753.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000234754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000234779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000234817.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000234848.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000234913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000234917.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000234998.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000235052.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000235070.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000235078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000235151.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000235159.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000235180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000235214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000235237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000235246.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000235262.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000235280.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000235313.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000235319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000235337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000235423.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000235427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000235453.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000235477.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000235522.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000235545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000235635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000235641.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000235663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000235706.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000235706.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000235772.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000235781.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000235786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000235837.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000235903.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000236066.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000236095.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000236098.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000236098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000236137.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000236144.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000236204.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000236206.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000236234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000236299.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000236384.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000236426.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000236472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000236528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000236540.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000236581.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000236643.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000236700.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000236711.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000236740.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000236751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000236824.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000236824.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000236859.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000236861.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000236889.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000236896.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000236901.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000236901.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000236914.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000236914.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000236977.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000237021.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237126.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000237181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000237200.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000237200.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000237253.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000237271.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000237499.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000237502.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237505.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237517.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000237520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000237520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000237523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000237531.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000237543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000237594.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000237685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000237685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000237705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000237721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000237737.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000237742.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000237773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000237819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000237845.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237870.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000237883.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000237886.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000237934.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000237934.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000237934.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000237938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000238005.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000238005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000238042.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000238057.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000238113.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000238117.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000238120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000238121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000238164.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000238197.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000238198.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000238198.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000238210.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000238261.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000238261.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000238266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000238290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000239002.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000239213.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000239353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000239377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000239480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000239498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000239593.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000239608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000239636.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000239664.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000239801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000239828.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000239911.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000240005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000240006.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000240006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000240015.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000240015.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000240032.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000240093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000240095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000240288.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000240499.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000240618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000240758.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000240875.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000240922.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000240996.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000241169.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000241280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000241288.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000241316.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000241599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000241666.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000241770.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000241818.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000241860.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000241990.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000241990.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000242078.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000242078.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000242078.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000242104.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000242136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000242154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000242207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000242282.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000242391.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000242396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000242516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000242516.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000242759.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000242797.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000242798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000242861.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000243069.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000243230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000243243.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000243384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000243479.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000243491.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000243533.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000243637.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000243766.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000243902.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000243926.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000244161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000244260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000244327.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000244468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000244586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000244649.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000244998.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000245059.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000245067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000245105.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000245164.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000245164.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000245330.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000245479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000245479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000245522.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000245526.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000245552.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000245556.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000245571.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000245571.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000245648.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000245667.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000245729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000245954.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000245975.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000246067.3 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000246263.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000246334.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000246422.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000246526.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000246548.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000247011.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000247134.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000247240.3 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000247516.3 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000247853.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000248027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000248112.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000248240.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000248275.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000248429.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000248476.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000248514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000248559.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000248596.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000248664.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000248668.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000248693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000248693.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000248714.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000248740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000248774.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000248787.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000248787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000248846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000248846.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000248896.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000248925.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000248927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000248964.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000249084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000249159.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000249167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000249258.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000249267.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000249356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000249451.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000249453.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000249595.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000249637.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000249637.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000249641.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000249685.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000249917.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000250015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000250061.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000250069.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000250132.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000250286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000250295.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000250362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000250451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000250551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000250616.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000250699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000250742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000250748.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000250829.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000250874.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000250899.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000250900.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000250934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000251072.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000251131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000251131.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000251136.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000251148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000251161.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000251194.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000251205.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000251307.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000251314.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000251330.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000251331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000251350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000251359.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000251396.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000251413.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000251432.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000251442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000251513.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000251555.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000251556.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000251615.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000251615.3 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000251661.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000253123.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000253161.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000253168.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000253168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000253190.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000253210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000253374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000253390.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000253394.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000253395.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000253404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000253445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000253477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000253508.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000253559.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000253603.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000253649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000253669.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000253696.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000253708.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000253716.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000253741.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000253741.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000253799.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000253844.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000253844.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000253848.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000253875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000253878.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000253893.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000253893.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000253898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000253917.3 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000253978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000254028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254109.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254144.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000254154.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000254207.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254233.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254258.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000254267.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000254281.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254286.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000254295.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254353.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000254353.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000254362.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254414.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254431.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000254459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254473.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000254480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000254485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000254495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000254526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254560.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000254592.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254606.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000254631.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000254632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000254710.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000254731.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000254812.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000254826.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000254826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254833.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000254900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000254910.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000254985.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000255031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000255031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000255052.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000255060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000255084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000255097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000255129.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000255135.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000255142.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000255142.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000255148.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000255165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000255182.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000255186.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000255202.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000255234.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000255237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000255247.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000255318.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000255328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000255337.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000255337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000255348.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000255449.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000255487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000255503.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000255507.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000255507.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000255516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000255545.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000255557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000255621.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000255621.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000255669.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000255857.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000255970.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000255989.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000255992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000256083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000256195.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000256250.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000256276.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000256299.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000256312.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000256360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000256448.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000256452.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000256458.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000256564.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000256576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000256588.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000256596.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000256603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000256690.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000256690.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000256746.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000256824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000256862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000256940.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000256967.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000256973.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000257086.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000257135.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000257283.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000257322.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000257329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000257329.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000257354.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000257354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000257496.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000257527.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000257556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000257557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000257647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000257663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000257711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000257769.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000257808.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000257815.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000257829.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000257830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000257842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000257913.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000257931.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000258101.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000258101.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000258171.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000258172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000258181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000258302.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000258413.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000258443.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000258457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000258520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000258520.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000258526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000258534.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000258545.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000258553.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000258623.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000258657.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000258689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000258701.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000258711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000258731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000258766.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000258858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000258926.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000258927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000258935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000258942.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000258946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000258949.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000258949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000258949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000258982.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259001.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000259002.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000259002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000259081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000259115.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000259125.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000259146.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000259146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259182.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259187.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000259209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000259230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259274.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259274.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259341.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000259370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259376.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259398.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259408.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259426.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000259448.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000259450.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259462.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000259475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000259551.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000259553.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000259575.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000259577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000259618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259631.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000259650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259672.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000259673.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000259682.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000259712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259717.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000259732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000259736.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000259758.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000259783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000259792.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000259797.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000259862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000259883.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000259894.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000259915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000259942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259943.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000259967.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000259994.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000260025.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260025.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000260065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000260084.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000260088.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000260100.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000260141.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000260179.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260209.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000260257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260278.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000260288.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260331.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260361.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000260369.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260394.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000260436.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000260441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260515.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000260528.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000260558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000260583.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000260585.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000260597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000260608.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000260630.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260641.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000260645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260646.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000260648.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000260655.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000260706.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000260742.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000260744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260787.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000260793.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260803.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260805.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000260814.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000260831.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000260841.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260871.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260918.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000260924.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260927.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000260931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260932.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000260932.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000260973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000260977.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000260977.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000260978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000260997.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000261002.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000261003.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000261039.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000261040.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000261045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000261094.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000261098.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000261118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000261167.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000261167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000261167.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000261172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000261173.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000261204.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000261216.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000261305.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000261305.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000261334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261355.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000261357.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000261373.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000261390.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000261393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261399.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000261423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000261428.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000261431.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000261431.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000261433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000261496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000261519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261526.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000261584.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000261600.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000261617.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261664.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000261692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000261697.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000261723.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000261775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000261775.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000261798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000261801.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000261821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000261823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000261864.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000261889.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000261916.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000261971.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000262133.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000262136.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262172.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000262185.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000262188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262202.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000262213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262223.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000262298.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000262380.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000262410.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000262454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000262521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262558.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000262580.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000262585.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262678.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000262692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000262693.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000262703.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000262721.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000262745.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000262766.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000262769.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000262877.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000262903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000262951.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000263004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000263214.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000263214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000263220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000263338.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000263400.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000263466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000263499.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000263531.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000263627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000263727.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000263731.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000263753.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000263753.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000263766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000263843.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000263874.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000263884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000263893.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000263924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000263924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000263934.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000264107.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000264107.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000264196.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000264235.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000264247.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000264269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000264448.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000264469.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000264486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000264548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000264548.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000264575.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000264575.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000264577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000264672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000264729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000264808.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000264853.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000264859.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000264859.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000264937.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000264956.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000264964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000265091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000265091.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000265121.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000265185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000265205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000265242.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000265242.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000265413.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000265485.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000265750.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000265750.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000265791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000265912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000266088.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000266120.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000266126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000266149.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000266289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000266289.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000266441.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000266456.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000266469.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000266498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000266538.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000266664.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000266709.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000266805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000266805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000266805.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000266904.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000266927.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000266930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000266934.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000266936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000266957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000266970.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000266970.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000266993.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000266993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267018.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000267067.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000267069.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000267082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000267117.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000267118.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267128.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000267128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267130.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000267131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000267141.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000267144.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000267161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000267192.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000267201.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267207.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000267219.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000267230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000267232.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000267249.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000267277.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000267279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000267288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267288.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267316.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000267321.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000267342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267344.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267348.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000267348.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000267348.2 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000267375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267395.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267397.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000267405.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267414.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000267429.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267439.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267470.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000267475.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000267479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000267480.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267480.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000267481.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000267505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000267530.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000267530.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000267613.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000267649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000267655.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000267658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267658.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000267666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267729.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000267737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000267737.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000267745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000267745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000267838.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267905.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000267919.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000267922.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000267927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000267934.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000268001.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000268047.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000268049.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000268093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000268199.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000268204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000268204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000268230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000268266.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000268289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000268333.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000268401.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000268499.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000268516.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000268530.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000268568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000268686.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000268751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000268756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000268895.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000268931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000268938.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000269044.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000269044.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000269161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000269191.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000269194.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000269202.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000269246.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000269365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000269423.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000269600.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000269680.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000269892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000269892.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000269900.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000269923.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000269927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000269934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000269938.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000269949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000269950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000269950.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000269956.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000269966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000269966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000269979.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000270018.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000270022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000270031.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000270038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000270041.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000270048.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000270055.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000270061.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000270069.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000270095.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000270103.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000270109.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000270117.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000270140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000270143.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000270143.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000270154.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000270154.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000270159.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000270170.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000270182.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000270190.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000270190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000270210.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000270246.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000270344.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000270419.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000270419.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000270462.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000270482.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000270482.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000270599.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000270750.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000270760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000270949.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000271032.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000271086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000271109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000271119.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271127.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000271147.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271172.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000271327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271335.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000271335.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000271335.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000271387.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000271390.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271427.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000271576.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000271584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271593.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000271646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271659.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000271811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000271815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000271833.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000271835.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000271843.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000271862.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000271889.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000271912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000271948.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000271966.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000271967.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000271978.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000271993.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000271998.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000272023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272024.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272048.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000272049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272079.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000272102.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000272123.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000272141.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272148.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000272156.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272158.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000272172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000272183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000272209.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000272221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272235.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272264.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000272301.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272304.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000272312.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000272327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000272343.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000272369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272373.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000272377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000272386.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272420.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272482.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000272505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000272523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000272523.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000272524.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000272562.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000272562.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000272566.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272568.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272597.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272657.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000272669.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000272690.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000272709.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000272716.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272720.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272761.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000272763.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Temsirolimus |
ENSG00000272787.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000272788.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272792.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000272799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000272799.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000272799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000272810.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000272828.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000272828.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000272829.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000272861.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000272861.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000272888.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000272905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000272908.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000272931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000272931.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000272933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000272960.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000272983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000272983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000273001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000273007.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000273007.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000273018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000273038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000273077.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000273091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000273093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000273096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000273108.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000273132.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000273132.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000273137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000273142.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000273145.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000273176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000273216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000273230.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000273230.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000273243.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000273245.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000273257.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000273257.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000273265.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000273265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000273271.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000273295.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000273301.1 |
Predicted lncRNA |
Sarcoma |
|
| Temsirolimus |
ENSG00000273306.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000273308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Temsirolimus |
ENSG00000273309.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000273329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Temsirolimus |
ENSG00000273335.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000273342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000273355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000273356.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Temsirolimus |
ENSG00000273369.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000273375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Temsirolimus |
ENSG00000273399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000273407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Temsirolimus |
ENSG00000273424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Temsirolimus |
ENSG00000273443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000273445.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Temsirolimus |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
ENSG00000273472.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Temsirolimus |
ENSG00000273476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Temsirolimus |
ENSG00000273488.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Temsirolimus |
ENSG00000273493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Temsirolimus |
GAS5-AS1 |
Curated lncRNA |
mantle cell lymphoma |
|
| Temsirolimus |
GAS5-AS1 |
Curated lncRNA |
prostate cancer |
|
| Temsirolimus |
hsa-miR-100-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-125b-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-128-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-137 |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-20a-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-20b-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-219a-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-221-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-26b-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-27a-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-33a-5p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-376a-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-376c-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-377-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-378a-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-429 |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-652-3p |
predicted miRNA |
NCI60 |
|
| Temsirolimus |
hsa-miR-99a-5p |
predicted miRNA |
NCI60 |
|